- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in Healthcare
Glenmark Defends Price Of Its COVID-19 Drug Favipiravir Version
Glenmark also denied making any claims that "favipiravir alone" is effective in treatment of mild-to-moderate COVID-19 patients.
Read More
EU In Talks With Moderna, BioNtech, CureVac To Secure Possible COVID Vaccines
The talks follow a deal reached in June by four EU member states with AstraZeneca for the upfront purchase of 400 million doses of its potential COVID-19 vaccine, in principle available to all 27 EU nations.
Read More
Infectious Disease Specialists Ask US Govt To Ensure Remdesivir Supply
"We urge the administration to fully leverage all authorities including the Defense Production Act and other tools to ensure adequate supplies of remdesivir," the IDSA said.
Read More
India Approves Human Trials For Second COVID-19 Vaccine Candidate
India's approval for Zydus comes days after privately held Bharat Biotech got a similar green light for human studies for its vaccine candidate.
Read More
Wall Street Shifts Bets To Big Pharma As COVID-19 Vaccine Race Progresses
Companies including Pfizer and Johnson & Johnson have said they each aim to produce as many as 1 billion doses by the end of 2021.
Read More
Covid-19 Vaccine Status: Here's All You Need To Know
Here is the latest update on COVID-19 vaccines from different pharmaceutical companies
Read More
BioNTech And Pfizer's COVID-19 Vaccine Shows Potential In Human Trial
The potential treatment is the fourth early-stage COVID-19 drug to show promise in human testing, along with projects involving Moderna, CanSino Biologics and Inovio Pharmaceuticals.
Read More
Oxford COVID-19 Vaccine Developers Encouraged By Immune Response But Cautious On Timeframe
"We're very happy that we're seeing the right sort of immune response that will give protection, and not the wrong sort," Gilbert said.
Read More
Gilead Prices COVID-19 Drug Remdesivir At $2,340 Per Patient In Developed Nations
Cipla's version is priced at less than 5,000 Indian rupees ($66.24), while Hetero Lab's version is priced at 5,400 rupees ($71.54).
Read More
Bharat Biotech Announces India's First COVID-19 Vaccine Candidate 'COVAXIN' With DCGI Approval For Human Clinical Trials
The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.
Read More
Temasek-Led Investor Group In $250 Million Vaccine Bet On Biontech
The investors are in for an early reckoning because BioNTech has said it expects first clinical data on its COVID-19 vaccine development programme known as BNT162 this month or in July.
Read More
CanSino's COVID-19 Vaccine Candidate Approved For Military Use In China
China's Central Military Commission approved the use of the vaccine by the military on June 25 for a period of one year,
Read More
Japan's Takeda Expects $200 Million Operating Loss Related To Novartis' Xiidra Withdrawal
Takeda sold Xiidra to Novartis for $3.4 billion upfront and up to an additional $1.9 billion in potential milestone receipts.
Read More
Carlyle Group To Buy 20% Stake In Piramal Pharma For Over Rs 3,700 Cr
The capital raise will accelerate Piramal Pharma's organic and inorganic growth plans,
Read More
Vaccine Makers Face Biggest Medical Manufacturing Feat In History
J&J has partnered with the U.S. government on a $1 billion investment to speed development and production of its vaccine, even before it's proven to work.
Read More